[
    [
        {
            "time": "2020-Q3",
            "original_text": "康龙化成(300759)2020三季报点评：Q3维持高增长 毛利率提升显着",
            "features": {
                "keywords": [
                    "康龙化成",
                    "三季报",
                    "Q3",
                    "高增长",
                    "毛利率"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "康龙化成(300759)2020三季报点评：Q3维持高增长 毛利率提升显着",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2020-Q3",
            "original_text": "康龙化成(300759)：实验室龙头企业 Q3延续二季度高速",
            "features": {
                "keywords": [
                    "康龙化成",
                    "实验室",
                    "龙头企业",
                    "Q3",
                    "高增速"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "康龙化成(300759)：实验室龙头企业 Q3延续二季度高速",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        },
        {
            "time": "2020",
            "original_text": "2020年医药股ESG报告：智飞生物减持超百亿，35家公司股东“清仓式减持” 减持股份",
            "features": {
                "keywords": [
                    "医药股",
                    "ESG报告",
                    "智飞生物",
                    "减持",
                    "清仓式减持"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "2020年医药股ESG报告：智飞生物减持超百亿，35家公司股东“清仓式减持” 减持股份",
                "Correlation": 5,
                "Sentiment": 3,
                "Importance": 7,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 6,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 5,
                "Source_Recency": 9
            }
        }
    ]
]